| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.075 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.095 | 0.6 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |